| Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant Y Gao, C Cai, A Grifoni, TR Müller, J Niessl, A Olofsson, M Humbert, ... Nature medicine 28 (3), 472-476, 2022 | 355 | 2022 |
| Orthotopic replacement of T-cell receptor α-and β-chains with preservation of near-physiological T-cell function K Schober, TR Müller, F Gökmen, S Grassmann, M Effenberger, ... Nature biomedical engineering 3 (12), 974-984, 2019 | 143 | 2019 |
| Reverse TCR repertoire evolution toward dominant low-affinity clones during chronic CMV infection K Schober, F Voit, S Grassmann, TR Müller, J Eggert, S Jarosch, ... Nature immunology 21 (4), 434-441, 2020 | 91 | 2020 |
| Immunodeficiency syndromes differentially impact the functional profile of SARS-CoV-2-specific T cells elicited by mRNA vaccination Y Gao, C Cai, D Wullimann, J Niessl, O Rivera-Ballesteros, P Chen, ... Immunity 55 (9), 1732-1746. e5, 2022 | 45 | 2022 |
| Targeted T cell receptor gene editing provides predictable T cell product function for immunotherapy TR Müller, S Jarosch, M Hammel, J Leube, S Grassmann, B Bernard, ... Cell Reports Medicine 2 (8), 100374, 2021 | 37 | 2021 |
| FLEXamers: a double tag for universal generation of versatile peptide-MHC multimers M Effenberger, A Stengl, K Schober, M Gerget, M Kampick, TR Müller, ... The Journal of Immunology 202 (7), 2164-2171, 2019 | 24 | 2019 |
| A T‐cell reporter platform for high‐throughput and reliable investigation of TCR function and biology TR Müller, C Schuler, M Hammel, A Köhler, S Jutz, J Leitner, K Schober, ... Clinical & translational immunology 9 (11), e1216, 2020 | 23 | 2020 |
| Efficient immunoaffinity chromatography of lymphocytes directly from whole blood F Mohr, S Przibilla, F Leonhardt, C Stemberger, S Dreher, TR Müller, ... Scientific reports 8 (1), 16731, 2018 | 19 | 2018 |
| Orthotopic T-cell receptor replacement—an “enabler” for TCR-based therapies K Schober, TR Müller, DH Busch Cells 9 (6), 1367, 2020 | 18 | 2020 |
| Additive effects of booster mRNA vaccination and SARS-CoV-2 Omicron infection on T cell immunity across immunocompromised states TR Müller, T Sekine, D Trubach, J Niessl, P Chen, P Bergman, O Blennow, ... Science translational medicine 15 (704), eadg9452, 2023 | 10 | 2023 |
| Orthotopic T-cell receptor replacement in primary human T cells using CRISPR-Cas9-mediated homology-directed repair C Moosmann, TR Müller, DH Busch, K Schober STAR protocols 3 (1), 101031, 2022 | 10 | 2022 |
| Ancestral SARS-CoV-2-specific T cells cross-recognize Omicron (B. 1.1. 529) Y Gao, C Cai, A Grifoni, T Müller, J Niessl, A Olofsson, M Humbert, ... | 5 | 2022 |
| Protective T cell receptor identification for orthotopic reprogramming of immunity in refractory virus infections TA Stief, T Kaeuferle, TR Müller, M Döring, LM Jablonowski, K Schober, ... Molecular Therapy 30 (1), 198-208, 2022 | 4 | 2022 |
| Boosting SARS-CoV-2 immunity in immunocompromised individuals TR Müller, M Buggert Genes & Immunity, 1-2, 2023 | 1 | 2023 |
| Beating Heart Preservation of Donor Hearts for Transplantation—A Working Heart Perfusion System for Pig Hearts to Extend Organ Preservation Time P Pritzwald-Stegmann, J Passage, T Müller, A Mühle, S Krabbes, S Dhein, ... Heart, Lung and Circulation 20 (1), 50-51, 2011 | 1 | 2011 |
| Early recognition of HCMV-pp65 antigen by CD8 T cells F Khan, L Cicin-Sain, TR Mueller, DH Busch, M Durand, A Ynga, ... EUROPEAN JOURNAL OF IMMUNOLOGY 52, 367-367, 2022 | | 2022 |
| Next-Generation TCR-transgenic T cells for Immunotherapy TR Müller Technische Universität München, 2021 | | 2021 |
| TCR reprogramming for the treatment of refractory adenovirus infection TA Stief, T Kaeuferle, T Mueller, K Schober, M Doering, KM Dennehy, ... EUROPEAN JOURNAL OF IMMUNOLOGY 49, 264-265, 2019 | | 2019 |
| TCR: pMHC koff-rate as a functional parameter for selecting T cell receptors with therapeutic value for adoptive cell therapy E D'Ippolito, M Effenberger, K Schober, A Hochholzer, F Graml, T Mueller, ... EUROPEAN JOURNAL OF IMMUNOLOGY 49, 275-275, 2019 | | 2019 |
| T cell receptor avidity-dependent T cell fate during infection and tumor disease K Schober, F Voit, A Purcarea, T Mueller, S Grassmann, D Busch EUROPEAN JOURNAL OF IMMUNOLOGY 49, 269-269, 2019 | | 2019 |
